Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor
2013-004412-22Phase 2Terminated
- Sponsor
- Uppsala Clinical Research Center
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Dyspnoea (SOB) comparing Caffeine with Placebo (2 arms). Primary endpoint: Dyspnea VAS AUC. Started Oct 2014; status: terminated.
02
Drugs
caffeine
03
Conditions
Dyspnoea (SOB)
Beyond the preview
Go deeper on 2013-004412-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004412-22.